Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: Report from an international workshop

Genes Chromosomes and Cancer

Volumn 33, Issue 4, 2002, Pages 401-412

  Block, AnneMarie W ^a   Carroll, Andrew J ^b   Hagemeijer, Anne ^c   Michaux, Lucienne ^d   Van Lom, Kirsten ^e   Olney, Harold J ^f,g   Baer, Maria R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Center for Human Genetics   (Belgium)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF CHICAGO   (United States)

^g CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; GYRASE INHIBITOR;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; BREAST CANCER; CHILD; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CONFERENCE PAPER; FEMALE; GEOGRAPHIC DISTRIBUTION; HODGKIN DISEASE; HUMAN; KARYOTYPE; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0036194105     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10044     Document Type: Conference Paper

References (53)

1. The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion
2. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements
3. Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescence in situ hybridization analysis
4. Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia
5. t(1;3)(p36;q21) in acute nonlymphocytic leukemia: A new cytogenetic-clinicopathologic association
6. The t(7;11)(p15;p15) translocation in acute myeloid leukemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9
7. The translocation t(8;16)(p11;p13) of acute myeloid leukemia fuses a putative acetyltransferase to the CREB-binding protein
8. Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11
9. Identification and molecular characterization of CALM/AF10 fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemia
10. The tyrosine kinase ABL-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): Molecular cloning of both reciprocal transcripts
11. A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia
12. Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13)
13. Translocation t(6;9) occurring in acute myelofibrosis, myelodysplastic syndrome, and acute nonlymphocytic leukemia suggests multipotent stem cell involvement
14. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family
15. MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): Both rearrangements are associated with a poor prognosis
16. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26)
17. Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)
18. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial
19. Clinical, haematological and molecular studies in patients with chromosome translocation t(7;11): A study of four Chinese patients in Taiwan
20. t(1;3)(p36;q21)
21. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome
22. Combination of classical and interphase cytogenetics to investigate the biology of myeloid disorders: Detection of masked monosomy 7 in AML
23. Data management and statistical methods used in the analysis of balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and therapy-related acute leukemia: Report from an International Workshop
24. Inversion of chromosome 11, inv(11)(p15q22), as a recurring chromosomal aberration associated with de novo and secondary myeloid malignancies: Identification of a P1 clone spanning the 11q22 breakpoint
25. Racial predisposition to translocation (7;11)
26. Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine
27. Mutagen exposures and chromosomes 3 aberrations in acute myelocytic leukemia
28. MLL amplification in myeloid leukemias: A study of 14 cases with multiple copies of 11q23
29. Reciprocal 8;14 translocation in EBV-negative B-cell acute lymphocytic leukemia with Burkitt-type cells
30. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia
31. Isochromosome (17)(q10) and translocation (4;12)(q12;p13) in a child with acute myeloid leukemia
32. 11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome
33. Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL
34. Many unbalanced translocations show duplication of a translocation participant
35. Two different classes of therapy-related and de-novo acute myeloid leukemia?
36. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse
37. Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a cooperative pediatric oncology group study - POG 8821
38. The NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia
39. Nonrandom chromosomal abnormalities in acute non-lymphocytic leukemia in patients treated for Hodgkin disease and non-Hodgkin lymphomas
40. International Workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: Overview report
41. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies
42. Therapy-related acute myeloid leukemia with t(10;11)(q23;p15) following successful chemotherapy for acute promyclocytic leukemia with t(15;17)(q22;q21)
43. Acute promyelocytic leukemia: Report of a variant translocation, t(1;17)
44. Identification of breakpoint cluster regions at 1p36.3 and 3q21 in hematologic malignancies with t(1;3)(p36;q21)
45. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group study
46. Involvement of 11p15 and 3q21-26 in therapy-related myeloid leukemia (t-AML) in children
47. Correlation of cytogenetic, molecular cytogenetic and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12
48. Occurrence of a novel t(11;19)(q13;q13.3) in complete remission of acute promyelocytic leukemia
49. Translocations involving 12p in acute leukemia: Association with prior myelodysplasia and exposure to mutagenic agents
50. Treatment-related chronic myelogenous leukemia
51. Two cases of acute promyelocytic leukemia with variant translocations: The importance of chromosome no. 17 abnormality